Hyaluronic Acid Market Size, Share & Trends Report

Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), And Segment Forecasts, 2024 - 2030

Report ID: 978-1-68038-333-1
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2018 - 2022
Industry: Healthcare

Market Segmentation

Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
- Dermal fillers
- Osteoarthritis
- Ophthalmic
- Vesicoureteral reflux
Hyaluronic Acid Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Dermal fillers
    - Osteoarthritis
    - Ophthalmic
    - Vesicoureteral reflux
  - U.S.
    - U.S. Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Canada
    - Canada Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
- Europe
  - Europe Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Dermal fillers
    - Osteoarthritis
    - Ophthalmic
    - Vesicoureteral reflux
  - UK
    - UK Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Germany
    - Germany Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - France
    - France Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Italy
    - Italy Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Spain
    - Spain Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Denmark
    - Denmark Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Sweden
    - Sweden Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Norway
    - Norway Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
- Asia Pacific
  - Asia Pacific Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Dermal fillers
    - Osteoarthritis
    - Ophthalmic
    - Vesicoureteral reflux
  - China
    - China Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Japan
    - Japan Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - India
    - India Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Australia
    - Australia Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Thailand
    - Thailand Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - South Korea
    - South Korea Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
- Latin America
  - Latin America Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Dermal fillers
    - Osteoarthritis
    - Ophthalmic
    - Vesicoureteral reflux
  - Brazil
    - Brazil Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Mexico
    - Mexico Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Argentina
    - Argentina Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
- Middle East & Africa
  - Middle East & Africa Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Dermal fillers
    - Osteoarthritis
    - Ophthalmic
    - Vesicoureteral reflux
  - South Africa
    - South Africa Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Saudi Arabia
    - Saudi Arabia Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - UAE
    - UAE Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux
  - Kuwait
    - Kuwait Hyaluronic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Dermal fillers
      - Osteoarthritis
      - Ophthalmic
      - Vesicoureteral reflux

Hyaluronic Acid Market Dynamics

Driver: Increasing Geriatric Population

The global geriatric population is rapidly rising. As per the World Health Organization (WHO) estimates, the global populace among the age group of 65 years and above is predicted to rise from 7% in 2000 to 16% in 2050. As per the Department of Economic & Social Affairs of the UN, the population over 80 years of age is anticipated to grow three times by 2050, reaching 425 million. As per the U.S. Census Bureau, at present, 54 million adults in the U.S. are 65 or above, making it 16% of the total population. Furthermore, Asia Pacific also holds the highest aging population record. According to the recent-most statistics on the aging population, Japan has the highest aging population across the world with 29% of the nation’s population aged 65 & above. A related issue of this will be an upsurge in the prevalence of obesity, skin aging, and osteoarthritis which is predicted to substantially boost the demand for hyaluronic acid (HA) products over the forecast period.

Surging Consciousness Regarding Antiaging Products

Growing consciousness about antiaging products is predicted to upsurge the demand for antiaging cosmetic and aesthetic treatments. Due to their distinctive viscoelastic and moisturizing properties, paired with decreased toxicity levels, hyaluronic acid products are straightly impacted by surging demand for negligibly invasive antiaging solutions. At present, a huge number of people, specifically women, are worried about aesthetics and looking younger, increasing their general mindfulness about the antiaging section. The demand for hyaluronic acid-infused products as dermal fillers and the treatment of vesicoureteral reflux is predicted to rise, owing to the high cognizance and marginally invasive nature. In North America, demand for such products is on a higher side. According to a report by Allergan, 50% of men & women in Canada are aware of dermal fillers & prefer them as a better aesthetic choice in comparison with surgical methods. In emerging countries, people are well-informed due to improving access to information and accessibility to products.

Restraint : Adversarial Impacts Related with Hyaluronic Acid

There are few negative results concerned to the usage of hyaluronic acid cycles. In most of the HA injections, the complications are mild and transient. This involves bruising, bleeding, redness, and overcorrection of itching, wrinkles, and inflammation. Nevertheless, in few cases, severe negative problems, such as cerebrovascular accidents, necrosis, and vision loss are likely to arise. Other adversarial event that can arise owing to the usage of HA-based dermal fillers is the formation of nodules and lumps. For instance, high pressure is placed on the syringe while injecting, it can lead to the formation of large boluses of fillers. Furthermore, as per an article issued in the American Academy of Ophthalmology, HA dermal injections to the tear trough may result in malar edema in nearly 11% of cases. The repetitive pain-bearing linked with numerous injection cycles is also a deterrent. Due to this, numerous people are indecisive regarding dermal filler injections.

What Does This Report Include?

This section will provide insights into the contents included in this hyaluronic acid market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Hyaluronic acid market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Hyaluronic acid market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.